Ozanezumab
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1].
Product Specifications
Product Name Alternative
GSK1223249
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ozanezumab.html
Purity
99
Solubility
10 mM in DMSO
Smiles
[Ozanezumab]
Molecular Weight
(145.227 kDa)
References & Citations
[1]Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16 (3) :208-216.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99213/Ozanezumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99213/Ozanezumab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
CAS Number
[1310680-64-8]
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6187601-01 0.1 mL
ARFGEF1 (ADP-Ribosylation Factor Guanine Nucleotide-Exchange Factor 1(brefeldin A-inhibited), ARFGEP1, BIG1, D730028O18Rik, DKFZP434L057, P200) (PE)
Ask
View Details 
MBS6187601-02 5x 0.1 mL
ARFGEF1 (ADP-Ribosylation Factor Guanine Nucleotide-Exchange Factor 1(brefeldin A-inhibited), ARFGEP1, BIG1, D730028O18Rik, DKFZP434L057, P200) (PE)
Ask
View Details GTR15160863 1 Vial
Lentiviral human MOCOS shRNA (UAS) - Lentiviral human MOCOS shRNA (UAS, iRFP) (100)
Ask
View Details